• Skip to main content
  • Skip to header right navigation
  • Skip to site footer

Log in
  • Search
    • Search All SAGES Content
    • Search SAGES Guidelines
    • Search the Video Library
    • Search the Image Library
    • Search the Abstracts Archive
www.sages.org

SAGES

Reimagining surgical care for a healthier world

  • Home
    • Search
    • SAGES Home
    • SAGES Foundation Home
  • About
    • Awards
    • Who Is SAGES?
    • Leadership
    • Our Mission
    • Advocacy
    • Committees
      • SAGES Board of Governors
      • Officers and Representatives of the Society
      • Committee Chairs and Co-Chairs
      • Committee Rosters
      • SAGES Past Presidents
  • Meetings
    • SAGES NBT Innovation Weekend
    • SAGES Annual Meeting
      • 2026 Scientific Session Call for Abstracts
      • 2026 Emerging Technology Call for Abstracts
    • CME Claim Form
    • SAGES Past, Present, Future, and Related Meeting Information
    • SAGES Related Meetings & Events Calendar
  • Join SAGES!
    • Membership Application
    • Membership Benefits
    • Membership Types
      • Requirements and Applications for Active Membership in SAGES
      • Requirements and Applications for Affiliate Membership in SAGES
      • Requirements and Applications for Associate Active Membership in SAGES
      • Requirements and Applications for Candidate Membership in SAGES
      • Requirements and Applications for International Membership in SAGES
      • Requirements for Medical Student Membership
    • Member Spotlight
    • Give the Gift of SAGES Membership
  • Patients
    • Join the SAGES Patient Partner Network (PPN)
    • Patient Information Brochures
    • Healthy Sooner – Patient Information for Minimally Invasive Surgery
    • Choosing Wisely – An Initiative of the ABIM Foundation
    • All in the Recovery: Colorectal Cancer Alliance
    • Find A SAGES Surgeon
  • Publications
    • Sustainability in Surgical Practice
    • SAGES Stories Podcast
    • Patient Information Brochures
    • Patient Information From SAGES
    • TAVAC – Technology and Value Assessments
    • Surgical Endoscopy and Other Journal Information
    • SAGES Manuals
    • MesSAGES – The SAGES Newsletter
    • COVID-19 Archive
    • Troubleshooting Guides
  • Education
    • Wellness Resources – You Are Not Alone
    • Avoid Opiates After Surgery
    • SAGES Subscription Catalog
    • SAGES TV: Home of SAGES Surgical Videos
    • The SAGES Safe Cholecystectomy Program
    • Masters Program
    • Resident and Fellow Opportunities
      • MIS Fellows Course
      • SAGES Robotics Residents and Fellows Courses
      • SAGES Free Resident Webinar Series
      • Fluorescence-Guided Surgery Course for Fellows
      • Fellows’ Career Development Course
    • SAGES S.M.A.R.T. Enhanced Recovery Program
    • SAGES @ Cine-Med Products
      • SAGES Top 21 Minimally Invasive Procedures Every Practicing Surgeon Should Know
      • SAGES Pearls Step-by-Step
      • SAGES Flexible Endoscopy 101
    • SAGES OR SAFETY Video Activity
  • Opportunities
    • Fellowship Recognition Opportunities
    • SAGES Advanced Flexible Endoscopy Area of Concentrated Training (ACT) SEAL
    • Multi-Society Foregut Fellowship Certification
    • Research Opportunities
    • FLS
    • FES
    • FUSE
    • Jobs Board
    • SAGES Go Global: Global Affairs and Humanitarian Efforts
  • OWLS/FLS
You are here: Home / Abstracts / The immediate re- resection of T1 incidental gallbladder carcinoma- indication or over treatment

The immediate re- resection of T1 incidental gallbladder carcinoma- indication or over treatment

Introduction: The indication for an immediate re-resection (IRR) in T1b incidental gallbladder carcinoma (IGBC) is debated in the literature, and different recommendations are often drawn based on data collected from only small groups. But the management of IGBC is difficult, because there are no established guidelines.
An IRR is recommended in cases of T2 tumours and more advanced stages according to many authors and the effective guidelines in of Germany.For a T1 tumour a simple cholecystectomy is enough.The IRR includes a liver resection and a loco regional lymphadenectomy. In which T- stage such a re- resection should be undertaken is debated in the international literature.
Some authors recommend a re resection in case of T1b- stage and improve the 5 year survival from 60 to 100%, because the rate of positive lymph nodes is up to 16% and the lymphatic, venous and perineural infiltration is up to 50% according to the literature.
Others recommend a reoperation only when the margins are positive or when there is subserosal invasion > 2mm.
The question is, if T1b tumours do profit from a re- resection or if this operation is only an additional lethality, the same question has to be discussed for T3 and T4 tumours.
Material and method: To obtain data we use the German- Registry of incidental gallbladder carcinoma, which is institution of the German Society of Surgery.Within a period of 3 months we are actualizing the data.
Results: 550 cases of incidental gallbladder carcinomas are registered.
In 79 patients with T1- tumour there was no IRR.In 31 patients with T1- tumour there was an IRR. According to Kaplan- Meier graph for T1- tumours,there is a significant prognostic advantage for T1- tumours with an IRR.
In 138 patients with T2- tumours there was no IRR.In 117 patients with T2- tumour there was an IRR. According to Kaplan- Meier for T2- tumours there is a significant prognostic advantage for T2- tumours with IRR.
The Kaplan- Meier graphs for T3 and T4- tumours indicate no survival benefit after IRR.
Discussion: There is a significant survival benefit for the T2 tumours and T1b- tumours after an IRR (log- rank < 0,05). The analysis shows no advantage for T1a and T3/4 carcinomas after IRR. An IRR should be highly recommended for patients with IGBC in the T1b stage. An extended resection is also necessary in order to exactly determine the nodal status, to make an exact definite staging for these patients, and to separate nodal negative patients (Stage Ia, IIb) from those with positive lymph-nodes.


Session: Podium Presentation

Program Number: S113

154

Share this:

  • Click to share on X (Opens in new window) X
  • Click to share on Facebook (Opens in new window) Facebook
  • Click to share on LinkedIn (Opens in new window) LinkedIn
  • Click to share on Pinterest (Opens in new window) Pinterest
  • Click to share on WhatsApp (Opens in new window) WhatsApp
  • Click to share on Reddit (Opens in new window) Reddit
  • Click to share on Pocket (Opens in new window) Pocket
  • Click to share on Mastodon (Opens in new window) Mastodon
  • Click to share on Threads (Opens in new window) Threads
  • Click to share on Bluesky (Opens in new window) Bluesky

Related


sages_adbutler_leaderboard

Hours & Info

11300 West Olympic Blvd, Suite 600
Los Angeles, CA 90064

1-310-437-0544

[email protected]

Monday – Friday
8am to 5pm Pacific Time

Find Us Around the Web!

  • Bluesky
  • X
  • Instagram
  • Facebook
  • YouTube

Copyright © 2025 · SAGES · All Rights Reserved

Important Links

Healthy Sooner: Patient Information

SAGES Guidelines, Statements, & Standards of Practice

SAGES Manuals